Role of PD-1 in regulating T-cell immunity
- PMID: 21061197
- DOI: 10.1007/82_2010_116
Role of PD-1 in regulating T-cell immunity
Abstract
Programmed cell death-1 (PD-1) is a member of the CD28 superfamily that delivers negative signals upon interaction with its two ligands, PD-L1 or PD-L2. PD-1 and its ligands are broadly expressed and exert a wider range of immunoregulatory roles in T cells activation and tolerance compared with other CD28 members. Subsequent studies show that PD-1-PD-L interaction regulates the induction and maintenance of peripheral tolerance and protect tissues from autoimmune attack. PD-1 and its ligands are also involved in attenuating infectious immunity and tumor immunity, and facilitating chronic infection and tumor progression. The biological significance of PD-1 and its ligand suggests the therapeutic potential of manipulation of PD-1 pathway against various human diseases. In this review, we summarize our current understanding of PD-1 and its ligands ranging from discovery to clinical significance.
Similar articles
-
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.Immunol Rev. 2008 Aug;224:166-82. doi: 10.1111/j.1600-065X.2008.00662.x. Immunol Rev. 2008. PMID: 18759926 Review.
-
PD-1 and its ligands in T-cell immunity.Curr Opin Immunol. 2007 Jun;19(3):309-14. doi: 10.1016/j.coi.2007.04.012. Epub 2007 Apr 12. Curr Opin Immunol. 2007. PMID: 17433872 Review.
-
The PD-1/PD-Ls pathway and autoimmune diseases.Cell Immunol. 2014 Jul;290(1):72-9. doi: 10.1016/j.cellimm.2014.05.006. Epub 2014 May 27. Cell Immunol. 2014. PMID: 24908630 Review.
-
Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.Arch Pharm Res. 2010 Nov;33(11):1825-33. doi: 10.1007/s12272-010-1115-3. Epub 2010 Nov 30. Arch Pharm Res. 2010. PMID: 21116786
-
The road to recovery: translating PD-1 biology into clinical benefit.Trends Immunol. 2007 Feb;28(2):48-50. doi: 10.1016/j.it.2006.12.001. Epub 2006 Dec 22. Trends Immunol. 2007. PMID: 17188572
Cited by
-
Within-host bayesian joint modeling of longitudinal and time-to-event data of Leishmania infection.PLoS One. 2024 Feb 9;19(2):e0297175. doi: 10.1371/journal.pone.0297175. eCollection 2024. PLoS One. 2024. PMID: 38335163 Free PMC article.
-
Development of small-molecular-based radiotracers for PET imaging of PD-L1 expression and guiding the PD-L1 therapeutics.Eur J Nucl Med Mol Imaging. 2024 Jan 22. doi: 10.1007/s00259-024-06610-3. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38246910
-
Pulmonary toxicity of immune checkpoint immunotherapy.J Clin Invest. 2024 Jan 16;134(2):e170503. doi: 10.1172/JCI170503. J Clin Invest. 2024. PMID: 38226621 Free PMC article. Review.
-
Immune checkpoint inhibitors break whose heart? Perspectives from cardio-immuno-oncology.Genes Dis. 2023 Mar 24;11(2):807-818. doi: 10.1016/j.gendis.2023.01.024. eCollection 2024 Mar. Genes Dis. 2023. PMID: 37692505 Free PMC article. Review.
-
Mechanical force regulates ligand binding and function of PD-1.bioRxiv [Preprint]. 2023 Aug 15:2023.08.13.553152. doi: 10.1101/2023.08.13.553152. bioRxiv. 2023. PMID: 37645980 Free PMC article. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
